Genta Incorporated (OTCBB: GETA) announced that the Company has initiated regimen of the first subject in a new Phase 2 trial of tesetaxel in senior
idioms:along


copyrights:cite this source roget's ii: the new dictionary melanoma. Tesetaxel is the Company's newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development. The new trial builds on more than ten years of Genta's adeptness in melanoma clinical research. Unlike llc.cite this source roget's ii: the new thesaurus taxanes (paclitaxel or docetaxel ) that must be infused intravenously, tesetaxel is a capsule that can be taken by mouth...

More: - Read the rest here